Overview


Onychomycosis refers to a fungal infection that affects the fingernails and toenails. It involves the nail bed as well as the underside of the nail. The nail becomes white, opaque, thickened and brittle due to this infection. This condition can also be found in hair and stratum corneum. Trichophyton and Epidermophyton are the most common causes of onychomycosis. They are also known as Dermatophytosis. Onychomycosis is a fungal nail infection that causes discoloration and thickening. This infection accounts for approximately one-third the global fungal infections. Dermatophytic Onychomycosis (also known as tinea unguium) is a fungal nail infection that is caused by dermatophytes. Dermatophytes are fungi which require keratin to grow. Dermatophytic Onychomycosis, which affects both fingernails and toenails, is the most common type of nail infection. Dermatophytic Onychomycosis refers to a fungal infection that affects the nail plate, nail beds, and sometimes the skin around the nail plate. The most common causes are yeast, dermatophytes and molds. In fact, 90% of cases are caused by dermatophytes. Trichophyton rubrum and Trichophyton mentagrophytes are the most common fungi that infect skin, hair, and nails. People often consider it to be a contagious and active infection. If not treated, onychomycosis can persist or get worse.
Onychomycosis can be caused by fungi found in floors, soil, socks, shoes, and other common places. There are two options for treating onychomycosis: debridement or drugs. Debridement can be time-consuming and not very effective in eliminating the fungal infection. Onychomycosis can be treated with systemic drug therapy. Dermatophytic Onychomycosis, also known as tinea unguium or toenail fungus, causes ring infections over nails. Trichophyton rubrum and Trichophyton mentagrophytes are two mutual strains of fungi that can cause dermatophytic mycosis. Global dermatophytic market for onychomycosis is driven by a rise in the prevalence of dermatophytic omycosis, an increase in the geriatric population susceptible to diabetes, sedentary lifestyle and a high demand for nails with aesthetic appearance. The market is constrained by side effects and insufficient awareness of dermatophytic mycosis. In the near future, there will be many opportunities for market expansion due to improvements in healthcare infrastructure and awareness of fungal nail infections in emerging countries.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Dermatophytic Onychomycosis Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Dermatophytic Onychomycosis Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

• Valeant Pharmaceuticals International Inc
• Novartis AG
• Pfizer Inc
• Johnson
Johnson
• Galderma S.A.
• Moberg Pharma AB
• Allergan Plc
• GlaxoSmithKline Plc
• Sanofi S.A.
• NovaBiotics Inc
(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product
• Nail Paint
• Tablet
o Prescription Tablets
o Over the Counter Tablets
By Route of Administration
• Topical
• Oral Therapy
By End-User
• Hospitals
• Dermatology and Podiatry Clinics
• Independent Pharmacies
• Mail Order Pharmacies
• Drug Stores
By Region
• North America
Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

• To provide with an exhaustive analysis on the Dermatophytic Onychomycosis Market By Product, By Route of Administration, By End-User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Dermatophytic Onychomycosis Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances
  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Dermatophytic Onychomycosis Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Dermatophytic Onychomycosis Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Dermatophytic Onychomycosis Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Nail Paint
        2. Tablet
         2.1. Prescription Tablets
         2.2. Over the Counter Tablets
  • 8.   Dermatophytic Onychomycosis Market, By Route of Administration Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Topical
        2. Oral Therapy
  • 9.   Dermatophytic Onychomycosis Market, By End-User Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Hospitals
        2. Dermatology and Podiatry Clinics
        3. Independent Pharmacies
        4. Mail Order Pharmacies
        5. Drug Stores
  • 10.   North America Dermatophytic Onychomycosis Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
           2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2022-2028
  • 11.   Latin America Dermatophytic Onychomycosis Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2022-2028
  • 12.   Europe Dermatophytic Onychomycosis Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Germany
          2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2022-2028
  • 13.   Asia Pacific Dermatophytic Onychomycosis Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
  • 14.   Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2022-2028
  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Valeant Pharmaceuticals International Inc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Novartis AG
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Pfizer Inc
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Johnson
      Johnson
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
          5. Galderma S.A.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Moberg Pharma AB
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Allergan Plc
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. GlaxoSmithKline Plc
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
          9. Sanofi S.A.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.NovaBiotics Inc
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients